Monday, May 16, 2016

BRIEF-OncoTherapy Science gets patent license

* Says the patent is for specific inhibitor of TOPK (T-LAK

cell-originated protein kinase), which being developed as an

anti-cancer agent

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)